These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3524563)

  • 1. Altered distribution of protein kinase C in dystrophic muscle cells and its modulation by liposome-delivered phospholipids.
    Cossu G; Adamo S; Senni MI; Caporale C; Molinaro M
    Biochem Biophys Res Commun; 1986 Jun; 137(2):752-8. PubMed ID: 3524563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phorbol esters and liposome-delivered phospholipids on the differentiation program of normal and dystrophic satellite cells.
    Cossu G; Senni MI; Eusebi F; Giacomoni D; Molinaro M
    Dev Biol; 1986 Nov; 118(1):182-9. PubMed ID: 3770298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of lipid composition in a dystrophic muscle cell line.
    Rabinowitz JL; Cossu G
    Biochim Biophys Acta; 1986 Dec; 879(3):394-8. PubMed ID: 3778929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-delivered phosphatidylcholine enhances the acetylcholine sensitivity of dystrophic mouse myotubes.
    Eusebi F; Cossu G; Molinaro M; Giacomoni D
    Biochim Biophys Acta; 1986 Feb; 855(1):197-9. PubMed ID: 3942742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal-muscle sarcolemma from normal and dystrophic mice. Isolation, characterization and lipid composition.
    de Kretser TA; Livett BG
    Biochem J; 1977 Nov; 168(2):229-37. PubMed ID: 597270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A muscle cell line from dystrophic mice expressing an altered phenotype in vitro.
    Senni MI; Eusebi F; Coletta M; Sommi M; Poiana G; Molinaro M; Cossu G
    Differentiation; 1986; 32(2):181-4. PubMed ID: 3792705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased calcium-activated neutral protease activity in muscles of dystrophic hamsters and mice.
    Neerunjun JS; Dubowitz V
    J Neurol Sci; 1979 Feb; 40(2-3):105-11. PubMed ID: 430097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered protein phosphorylation in murine muscular dystrophy.
    Senni MI; De Angelis L; Nervi C; Curci A; Barhanin J; Molinaro M; Cossu G
    J Neurol Sci; 1990 May; 96(2-3):303-19. PubMed ID: 2376759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid composition and metabolism in mouse muscular dystrophy.
    Kwok CT; Austin L
    Biochem J; 1978 Oct; 176(1):15-22. PubMed ID: 728103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells.
    Cossu G; Zani B; Coletta M; Bouchè M; Pacifici M; Molinaro M
    Cell Differ; 1980 Dec; 9(6):357-68. PubMed ID: 7438216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid composition of lipids in tongue and hindleg muscles of muscular dystrophic mice.
    Futo T; Hitaka T; Mizutani T; Okuyama H; Watanabe K; Totsuka T
    J Neurol Sci; 1989 Jul; 91(3):337-44. PubMed ID: 2769299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered membrane association of glycogen phosphorylase in the dystrophic chicken.
    Sokolove PM
    Biochim Biophys Acta; 1985 Aug; 841(2):232-6. PubMed ID: 4016151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characteristics of membrane fractions from cardiomyopathic and dystrophic muscle.
    Owens K; Weglicki WB; Ruth RC; Gottwik MG; McNamara DB; Sonnenblick
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():245-57. PubMed ID: 172989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered acetylcholinesterase isozyme patterns in mice with hereditary muscular dystrophy.
    Kuhn DE; Logan DM; Rathbone MP
    J Exp Zool; 1981 May; 216(2):213-33. PubMed ID: 7241063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts.
    Huard J; Labrecque C; Dansereau G; Robitaille L; Tremblay JP
    Muscle Nerve; 1991 Feb; 14(2):178-82. PubMed ID: 2000106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in enzyme efflux from dystrophic mouse skeletal muscle and heart.
    Morgan J; Bozyk ME; Bittner S; Cohen L
    Res Commun Chem Pathol Pharmacol; 1980 Dec; 30(3):555-76. PubMed ID: 7255864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes.
    Basset O; Boittin FX; Cognard C; Constantin B; Ruegg UT
    Biochem J; 2006 Apr; 395(2):267-76. PubMed ID: 16393138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties and distribution of mammalian skeletal muscle guanylate cyclase. Alterations in denervated and dystrophic muscle.
    Blosser JC; Appel SH
    J Biol Chem; 1978 May; 253(9):3088-93. PubMed ID: 25279
    [No Abstract]   [Full Text] [Related]  

  • 19. The dystrophic murine skeletal muscle cell plasma membrane is structurally intact but "leaky" to creatine phosphokinase. A freeze-fracture analysis.
    Shivers RR; Atkinson BG
    Am J Pathol; 1984 Sep; 116(3):482-96. PubMed ID: 6476081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of glycogen phosphorylase in normal and dystrophic muscle.
    Leyland DM; Beynon RJ
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):113-7. PubMed ID: 1883323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.